Lifeward Ltd. regained compliance with Nasdaq Listing Rule 5605(c)(2)(A) after appointing three new Audit Committee members following a prior non-compliance notice due to a director resignation.
Key takeaways
Company received Nasdaq notice for non-compliance with Audit Committee size requirement after Hadar Levy's resignation from Board and Audit Committee.
Nasdaq provided cure period until earliest of next annual shareholder meeting or February 24, 2027, or August 24, 2026 if meeting held before then.
On March 30, 2026, appointed Moshe Rozenbaum, William Mark Sigsbee, and Yehuda Reznick to Audit Committee.
Nasdaq confirmed compliance with Rule 5605(c)(2)(A) and closed the matter.